This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
UK pharma group raises long-term annual sales forecast to more than £40bn by 2031
Western drugmakers look to Chinese trials for early data on treatments’ potentia...
CVMP opinions on veterinary medicinal productsThe Committee adopted by consensus...
Medicines containing semaglutide: PRAC investigating risk of rare eye conditionP...
In 2024, EMA recommended 114 medicines for marketing authorisation. Of these, 46...
EMA has published the revised version of its policies on the handling of competi...
EMA is ready to support the implementation of the new regulation on health techn...
From today, all clinical trials in the European Union (EU), including ongoing tr...
Eight new medicines recommended for approvalEMA’s human medicines committee (CHM...
For the first time, the five EU health and environment agencies – EFSA (European...
The European Shortages Monitoring Platform (ESMP) is now live with the full scop...
EMA is celebrating 30 years of operations marking its evolving role at the centr...
EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 to ...
FDA approved Symvess, the first acellular tissue engineered vessel for use in ad...
The FDA issued draft guidance that, when finalized, will provide recommendations...
The FDA issued draft guidance to provide recommendations on the use of artificia...
Today, the U.S. Food and Drug Administration issued draft guidance that includes...
The FDA published new draft guidance aimed at helping improve the accuracy and p...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN ...
FDA issued a proposed rule that, if finalized, would make cigarettes and certain...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
FDA announces a proposed rule requiring food manufacturers to display a front-of...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...